On Running $858.4 million IPO
We advised On Holding on its IPO and NYSE listing
Experience
To find Davis Polk deals and cases of particular interest, select filters based on practice, industry, region, lawyer and keyword.
Filters
SOPHiA GENETICS $234 million IPO and $20 million private placement
We advised SOPHiA GENETICS on its IPO, Nasdaq listing and concurrent private placement
GXO Logistics $800 million notes offering
We advised the initial purchasers on the investment-grade debt offering
XPO Logistics $794 million follow-on and secondary offering
We advised the underwriters on the SEC-registered stock offering
GH Research $184 million IPO
We advised GH Research on the IPO and Nasdaq Listing
Energizer Gamma Acquisition €650 million notes offering
We advised the initial purchasers on the high-yield notes offering
Cyteir Therapeutics $133.2 million IPO
We advised the underwriters on the IPO and Nasdaq listing
Molecular Partners $64 million IPO
We advised the joint book-running managers and underwriters on the IPO and Nasdaq listing
Ayala Pharmaceuticals $20 million at-the-market offering
We advised the sales agent on the stock offering
UiPath $1.54 billion IPO
The shares are listed on the New York Stock Exchange